News


Stay tuned and learn Genekor’s latest news and updates on Molecular Oncology.

10.12.2021

San Antonio Breast Cancer Symposium 2021

The poster of the study conducted by Genekor’s Scientific Team "Different Copy Number Variations (CNVs) account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing" was presented at the San Antonio Breast Cancer Symposium 2021.

read more
11.12.2020

SABCS - RxPONDER TRIAL Study

RxPONDER Study Results Demonstrate that the Oncotype DX®
Test Can Now Spare Chemotherapy Use in the Majority of Women
with Node-positive Early-stage Breast Cancer.

read more
Change cookies consent Revoke cookies consent